 SAN DIEGO and SUZHOU, China, May 12, 2022 GLOBE NEWSWIRE -- Adagene Inc. Adagene Nasdaq: ADAG, a company transforming the discovery and development of novel antibody-based therapies, today announced that members of the companys management will participate in the following upcoming investor conferences: 